Portfolio company
Organoids Hubrecht Instituut
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops patient-derived 3D mini-organs from stem cells to provide drug discovery and preclinical testing services for pharmaceutical and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Bullseye Bio
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
RadaHaim
This company provides scalable organoid mass production platforms and research services to pharmaceutical firms and clinicians for drug discovery and toxicity screening.
Organovo
The company develops three-dimensional human tissues for drug discovery applications for pharmaceutical and biotechnology researchers.
Intero Biosystems
The company develops human intestinal organoid platforms for pharmaceutical and biotechnology firms to replace animal testing in preclinical drug discovery and safety assessment.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
Epiloid Biotechnology
This company provides preclinical research services using human brain organoids to help pharmaceutical firms test the efficacy and safety of neurological drug candidates.
